Data sets used in this study are available from the Korea Centers for Disease Control and Prevention database (2007-2014). <http://cdc.go.kr/CDC/contents/CdcKrContentView.jsp?cid=60940&menuIds=HOME001-MNU1130-MNU1639-MNU1748-MNU1752>

Introduction {#sec001}
============

The World Health Organization (WHO) Global Health Estimates (GHE) and World Bank-commissioned Global Burden of Disease (GBD) study measure the overall burden of disease using disability-adjusted life years (DALYs) \[[@pone.0172001.ref001]\]. This time-based measure combines years of life lost due to premature mortality (YLLs) and years lost due to time lived in states of less than full health (years lived with disability \[YLDs\]). YLDs are determined by non-fatal health outcomes of diseases and injuries; chronic noncommunicable diseases and injuries with lifelong consequences contribute markedly to non-fatal burdens of disease.

Condition-specific YLDs can be computed as the prevalence of disease or injury multiplied by the disability-weight for that condition \[[@pone.0172001.ref002],[@pone.0172001.ref003]\], and their reliable quantification requires precise estimates of prevalence rates and disability-weights for those conditions. However, unfortunately, the epidemiological data currently available have limitations, including lack of information on severity distributions, inconsistent methods for measuring disability-weights, and wide variation in data sources, for most conditions \[[@pone.0172001.ref004]--[@pone.0172001.ref008]\]. The GBD 2010 employed lay descriptions of the consequences of various diseases and injuries for developing universal measures of disability-weights, distinct from welfare and environments \[[@pone.0172001.ref009]\]. The WHO GHE also used the GBD 2010-developed disability-weights to calculate global and regional YLDs, after partially revising the values. However, it is arguable whether health and welfare can be separated and whether a universal approach is possible or even desirable \[[@pone.0172001.ref010]\]. Additionally, a brief lay description cannot reflect various manifestations of the same disease, the effect of treatment on disability, and adaptation to environments.

The Korea National Health and Nutrition Examination Survey (KNHANES) can facilitate estimation of condition-specific YLDs for noncommunicable diseases or injuries in the general population. This large population-representative survey, conducted by the Korea Centers for Disease Control and Prevention (KCDC), used the EQ-5D questionnaire to measure health-related quality of life. The EQ-5D provides a simple descriptive profile and a single index value for health status, simplifying disability-weight calculation. The survey also includes health questionnaires and physical/laboratory examinations, allowing determination of prevalence rate and disability-weight for specific diseases and injuries. Thus, numerous condition-specific YLDs could be estimated from a single source.

The present study aimed to provide population-representative YLDs of noncommunicable diseases and injuries, based on the KNHANES data. Additionally, we compared the YLDs of this study to those of the GHE.

Materials and methods {#sec002}
=====================

Subjects and identification of conditions {#sec003}
-----------------------------------------

The KNHANES is a population-based, cross-sectional study on the health and nutritional status of the non-institutionalized Korean population. The KCDC conducted the survey using a stratified, multistage, clustered probability design to select a representative, nationwide sample \[[@pone.0172001.ref011]\]. KNHANES comprises a health questionnaire, physical/laboratory examinations, and a nutrition survey; to date, phase I (1998), II (2001), III (2005), IV (2007−2009), V (2010−2012), and VI (2013−2015) have been executed by the Korean government. Written informed consent was obtained from each participant in the KNHANES at enrollment.

The present study protocol was approved by Kangwon national university hospital institutional review board (IRB File No.: KNUH-2015-06-001). This study was based on KNHANES 2007−2014 data, as these surveys were conducted by a single organization, KCDC, using consistent methodology since 2007, and KNHANES 2015 data were not available at the time of this analysis.

Health-related quality of life was assessed using the Korean version of the EQ-5D health questionnaire. The EQ-5D comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension comprised three levels: no problems, moderate problems, and extreme problems. The combination of all dimensions and levels yields 243 unique health states. The EQ-5D index scores were calculated based on the Korean value set, which has been established based on a representative national sample using the time−trade-off method \[[@pone.0172001.ref012]\]. Scores of 1 and 0 correspond to optimal and worst health, judged to be equivalent to death, respectively.

Of the 65973 subjects participating in KNHANES 2007−2014, we excluded subjects younger than 20-years-old (n = 16444) and adults who did not complete the EQ-5D questionnaire (n = 4560). Thus, a total of 44969 subjects (18984 males and 25985 females) were included in this study ([Fig 1](#pone.0172001.g001){ref-type="fig"}).

![Flow chart of the study participants.](pone.0172001.g001){#pone.0172001.g001}

Physical and laboratory examinations {#sec004}
------------------------------------

Trained medical staff and medical specialists, including ophthalmologists, otolaryngologists, and dentists performed the physical examinations, following standardized procedures. Oral health examinations were conducted in mobile centers that traveled to each survey location. Dentists conducted the examinations with the participant seated in a dental chair. Before the oral examination, participants were informed about the procedures using intra-oral pictures, tooth models, and simulation patients. Pulmonary function tests were performed in participants aged ≥ 40 years, using dry rolling seal spirometers. The procedure was conducted by trained medical personnel, who underwent education sessions on pulmonary function tests and quality control prior to the study.

From July 2008 to December 2012, ophthalmological and otological examinations were conducted in the Korea National Health and Nutrition Examination Survey (KNHANES). These examinations were conducted by trained teams from mobile centers; use of such centers provided a standardized environment and equipment. Presenting visual acuity was measured using currently available refractive correction, if any, with an international standard vision chart based on the Snellen scale. Best-corrected visual acuity was measured using autorefraction and/or a pinhole. Details of ophthalmologic examinations, including autorefractometry, slit lamp biomicroscopy, fundus photography, intraocular pressure, and visual field (frequency-doubling technology) tests have been published elsewhere \[[@pone.0172001.ref013]\]. Each fundus image was reviewed twice: onsite by ophthalmologists or ophthalmological residents, and then by retina specialists. An audiometry test was conducted by well-trained examiners, and the air-conduction hearing threshold was measured in a soundproof booth using an automatic audiometer at 500, 1000, 2000, 3000, 4000, and 6000 Hz.

Since 2010, plain radiographs of the knee, hip, and lumbar spine have been obtained in participants aged ≥ 50 years. The radiographic images were reviewed by two radiologists. The degree of radiographic osteoarthritis was assessed according to the Kellgren−Lawrence grading system.

Blood samples were collected after at least an 8-h fast, and random spot urine samples were obtained. The samples were processed appropriately, immediately refrigerated, and transported in cold storage to the central laboratory within 24 h. Blood hemoglobin and routine chemistries, including glucose and creatinine levels, were analyzed using standard methods. From 2007 to 2012, serum ferritin levels were measured by immunoradiometric assay. Since 2008, serum creatinine levels have been standardized to isotope dilution mass spectrometry, and urine albumin levels have been measured by turbidimetric immunoassay since 2011.

Identification of conditions {#sec005}
----------------------------

We identified noncommunicable diseases and injuries from the cause list of the World Health Organization (WHO) Global Health Estimates (GHE).\[[@pone.0172001.ref002]\] The GHE list provides a set of mutually exclusive and collectively exhaustive categories. The causes in the list are categorized into three broad groups: (I) communicable, maternal, perinatal, and nutritional conditions; (II) noncommunicable diseases; and (III) injuries. Among a total of 79 individual diseases of group II, we selected 30 diseases that could be identified using information available from the KNHANES data. Those 30 diseases accounted for two-thirds of the total YLDs related to group II. Nine of 10 individual injuries of group III could be identified, and those accounted for nearly 100% of the total YLDs related to group III. Additionally, we selected iron-deficiency anemia, which accounted for a fourth of the total YLDs related to group I. Of the 40 identified conditions, five were divided into subcategories. [Table 1](#pone.0172001.t001){ref-type="table"} shows the study years and number of subjects analyzed for each condition.

10.1371/journal.pone.0172001.t001

###### Study years and number of subjects analyzed for each condition.

![](pone.0172001.t001){#pone.0172001.t001g}

  Condition                                                                                                  No. analyzed    2007   2008   2009   2010   2011   2012   2013   2014
  ---------------------------------------------------------------------------------------------------------- --------------- ------ ------ ------ ------ ------ ------ ------ ------
  Asthma, Cancers, Cirrhosis, Depression, Dermatitis, Ischemic heart disease, Rheumatoid arthritis, Stroke   44,967−44,969   √      √      √      √      √      √      √      √
  Iron-deficiency anemia                                                                                     33,089          √      √      √      √      √      √             
  Diabetes mellitus                                                                                          41,392          √      √      √      √      √      √      √      √
  Alcohol-use disorders                                                                                      33,969          √      √      √      √      √      √      √      
  Visual impairment                                                                                          25,884−28,127          √      √      √      √      √             
  Hearing impairment                                                                                         22,889                 √      √      √      √      √      √      
  Chronic obstructive pulmonary disease (Age ≥ 40 years)                                                     21,425          √      √      √      √      √      √      √      √
  Chronic kidney disease                                                                                     19,166                                      √      √      √      √
  Peptic ulcer                                                                                               17,069          √      √      √                                  
  Osteoarthritis, Back pain (Age ≥ 50 years)                                                                 11,559                               √      √      √      √      
  Back pain (Age 20−49 years)                                                                                8,955           √      √      √                                  
  Dental caries, Periodontal disease                                                                         20,154                               √      √      √      √      √
  Edentulism                                                                                                 43,536          √      √      √      √      √      √      √      √
  Injuries                                                                                                   44,955          √      √      √      √      √      √      √      √

Definition of diseases and injuries {#sec006}
-----------------------------------

We defined and classified iron-deficiency anemia according to the WHO criteria \[[@pone.0172001.ref014]\]. Diabetes mellitus was defined as fasting blood glucose levels ≥ 126 mg/dl, being on medication for raised blood glucose, or with a history of diagnosis of diabetes. Alcohol-use disorders were defined based on the Alcohol-Use Disorders Identification Test scores according to the WHO guidelines \[[@pone.0172001.ref015]\].

We defined glaucoma according to the criteria of the International Society of Geographical and Epidemiological Ophthalmology classification scheme: Category 1, the presence of reliable (fixation and false-positive error ≤ 1) abnormal visual field testing (≥ one location of reduced sensitivity) plus a vertical cup-to-disc ratio (VCDR) ≥ 0.7, or asymmetry of the VCDR ≥ 0.2, or the presence of optic disk hemorrhage, or a retinal nerve fiber layer defect; Category 2, a VCDR ≥ 0.9 or asymmetry of the VCDR ≥ 0.3, or the presence of a retinal nerve fiber layer defect with violation of the inferior−superior−nasal−temporal rule; or Category 3, an intraocular pressure ≥ 22 mmHg plus a visual acuity \< 3/60. Cataract was defined as nuclear (Lens Opacities Classification System \[LOCS\] III score ≥ 4 for nuclear opalescence or nuclear color), cortical (LOCS III score ≥ 2 for cortical cataracts), posterior subcapsular (LOCS III score ≥ 2 for posterior subcapsular), or mixed (more than one type per eye) based on comparison with standard photographs. The diagnoses of diabetic retinopathy and age-related macular degeneration were made by retina specialists based on fundus photography images using protocols from the Early Treatment for Diabetic Retinopathy Study and International Age-related Maculopathy Epidemiological Study Group. We defined visual impairment as a visual acuity \< 6/18 in the better eye, including uncorrected refractive errors according to the International Classification of Diseases-10.

Disabling hearing impairment was defined as an audiometric International Society of Otolaryngology value (average of values at 500, 1000, 2000, 4000 Hz) ≥ 41 decibels in the better ear, according to the WHO classification \[[@pone.0172001.ref016]\]. Chronic obstructive pulmonary disease was defined and classified based on pulmonary function test results according to the Global Initiative for Chronic Obstructive Lung Disease \[[@pone.0172001.ref017]\]. Chronic kidney disease was classified into risk categories according to the Kidney Disease Improving Global Outcomes guidelines \[[@pone.0172001.ref018]\]. Osteoarthritis was defined as the presence of knee or hip pain with Kellgren−Lawrence grading scales score ≥ 2 on the corresponding radiographic images. We assessed periodontitis using the WHO Community Periodontal Index \[[@pone.0172001.ref019]\]. Periodontal disease was defined as a Community Periodontal Index score ≥ 3 with symptoms of difficulty in chewing and recent toothache.

We defined cancers, depression, ischemic heart disease (myocardial infarction or angina), stroke, current asthma, current peptic ulcer, cirrhosis, atopic dermatitis, and rheumatoid arthritis as a physician-based diagnosis of each disease. Unintentional or intentional injuries were defined based on self-reported questionnaires.

We summarized the definition of each condition in [Table 2](#pone.0172001.t002){ref-type="table"}.

10.1371/journal.pone.0172001.t002

###### Definition of noncommunicable diseases and injuries.

![](pone.0172001.t002){#pone.0172001.t002g}

  GHE code   GHE disease                       KNHANES disease                                    Definition
  ---------- --------------------------------- -------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------
  0          All Causes                        All Causes                                         The number of the population multiplied by the mean score of the combined disability weight (= "1 − mean score of EQ-5D index")
  58         Iron-deficiency anemia            Iron-deficiency anemia                             
                                               Mild                                               Hb \< 13.0 g/dL in men or Hb \< 12.0 g/dL in non-pregnant women or Hb \<11.0 g/dL in pregnant women, with serum ferritin \<15 ug/L
                                               Moderate                                           Hb 8.0−10.9 g/dL in men and non-pregnant women or Hb 7.0−9.9 g/dL in pregnant women, with serum ferritin \<15 ug/L
                                               Severe                                             Hb \<8.0 g/dL in men and non-pregnant women or Hb \<7.0 g/dL in pregnant women, with serum ferritin \<15 ug/L
  64         Stomach cancer                    Stomach cancer                                     Physician diagnosed
  65         Colon and rectum cancers          Colon cancers                                      Physician diagnosed
  66         Liver cancer                      Liver cancer                                       Physician diagnosed
  68         Trachea, bronchus, lung cancers   Lung cancers                                       Physician diagnosed
  70         Breast cancer                     Breast cancer                                      Physician diagnosed
  71         Cervix uteri cancer               Cervix cancer                                      Physician diagnosed
  78         Other malignant neoplasms         Other malignancy                                   Physician diagnosed
  80         Diabetes mellitus                 Diabetes mellitus                                  Fasting blood glucose ≥ 7.0 mmol/L (≥ 126 mg/dL) or on medication for raised blood glucose or with a history of diagnosis of diabetes
  83         Unipolar depressive disorders     Depression                                         Physician diagnosed
  86         Alcohol-use disorders             Alcohol-use disorders                              
                                               Harmful drinking behavior                          Questionnaire-based AUDIT score 16−19
                                               Alcohol dependence                                 Questionnaire-based AUDIT score ≥ 20
  103        Glaucoma                          Glaucoma with visual impairment                    Intraocular pressure, fundus photography, and visual field test-based diagnosis of glaucoma with BCVA \< 6/18 in the better eye
  104        Cataracts                         Cataracts with visual impairment                   Slit lamp biomicroscopy-based diagnosis of cataract with BCVA \< 6/18 in the better eye
  105        Refractive errors                 Uncorrected refractive errors                      Autorefractometer-based diagnosis of refractive errors with presenting VA \< 6/18 and BCVA ≥ 6/18 in the better eye
  106        Macular degeneration              Macular degeneration with visual impairment        Fundus photography-based diagnosis of macular degeneration with BCVA \< 6/18 in the better eye
  107        Other vision loss                 Diabetic retinopathy with visual impairment        Fundus photography-based diagnosis of diabetic retinopathy with BCVA \< 6/18 in the better eye
  108        Other hearing loss                Disabling hearing impairment                       Audiometric International Society of Otolaryngology value ≥ 41 decibels in the better ear
  113        Ischemic heart disease            Ischemic heart disease                             Physician diagnosed
  114        Stroke                            Stroke                                             Physician diagnosed
  118        COPD                              COPD, age ≥ 40 years                               
                                               Mild                                               FEV1/FVC \< 70% and FEV1 ≥ 80% predicted
                                               Moderate                                           FEV1/FVC \< 70% and FEV1 50−79% predicted
                                               Severe                                             FEV1/FVC \< 70% and FEV1 \< 50% predicted
  119        Asthma                            Asthma                                             Physician diagnosed, current asthma
  122        Peptic ulcer disease              Peptic ulcer, gastric or duodenal                  Physician diagnosed, current peptic ulcer
  123        Cirrhosis of the liver            Cirrhosis of the liver                             Physician diagnosed
  127        Kidney diseases                   Chronic kidney disease                             
                                               Moderately increased risk                          eGFR \< 60 mL/min/1.73 m^2^ or ACR ≥ 3 mg/mmol (≥30 mg/g), excluding high risk or very high risk
                                               High risk                                          eGFR \< 45 mL/min/1.73 m^2^ or ACR ≥ 30 mg/mmol (≥ 300 mg/g) or eGFR \< 60 mL/min/1.73 m^2^ with ACR ≥ 3 mg/mmol (≥ 30 mg/g), excluding very high risk
                                               Very high risk                                     eGFR \< 30 mL/min/1.73 m^2^ or eGFR \< 45 mL/min/1.73 m^2^ with ACR ≥ 3 mg/mmol (≥ 30 mg/g) or eGFR \<60 mL/min/1.73 m^2^ with ACR ≥ 30 mg/mmol (≥ 300 mg/g)
  133        Skin diseases                     Atopic dermatitis                                  Physician diagnosed
  135        Rheumatoid arthritis              Rheumatoid arthritis                               Physician diagnosed
  136        Osteoarthritis                    OA, age ≥50 years                                  Knee pain with K-L grading scale ≥ 2 on knee X-ray or hip pain with K-L grading scale ≥ 2 on hip X-ray
  138        Back and neck pain                Back pain                                          
                                               Back pain with radiographic OA, age ≥50 years      Recent (within 3 months) back pain with duration of ≥ 1 month, with K-L grading scale ≥ 2 on lumbar spine X-ray
                                               Back pain without radiographic OA, age ≥50 years   Recent (within 3 months) back pain with duration of ≥1 month, with K-L grading scale \< 2 on L-spine X-ray
                                               Back pain, age 20−49 years                         Physician diagnosed, current back pain
  148        Dental caries                     Dental caries                                      Dental exam-based diagnosis of caries with difficulty chewing and recent (within 1 year) toothache
  149        Periodontal disease               Periodontal disease                                Dental exam-based diagnosis of periodontal disease with difficulty chewing and recent (within 1 year) toothache
  150        Edentulism                        Edentulism                                         Dental exam-based diagnosis of severe tooth loss needing full dentures
  153        Road injury                       Road injury                                        Self-reported, recent (within 1 year) road injury
  154        Poisonings                        Poisonings                                         Self-reported, recent (within 1 year) poisonings
  155        Falls                             Falls                                              Self-reported, recent (within 1 year) falls
  156        Fire, heat, and hot substances    Fire and heat injury                               Self-reported, recent (within 1 year) fire and heat injury
  157        Drowning                          Drowning                                           Self-reported, recent (within 1 year) drowning
  158        Exposure to forces of nature      Injuries from other mechanical forces              Self-reported, recent (within 1 year) injuries from other mechanical forces
  159        Other unintentional injuries      Other unintentional injuries                       Self-reported, recent (within 1 year) other unintentional injuries
  161        Self-harm                         Self-harm                                          Self-reported, recent (within 1 year) self-harm
  162        Interpersonal violence            Violence                                           Self-reported, recent (within 1 year) interpersonal violence

Abbreviations: GHE, Global Health Estimates; KNHANES, Korea National Health and Nutrition Examination Survey; Hb, hemoglobin; AUDIT, alcohol-use disorders identification test; VA, visual acuity; BCVA, best-corrected visual acuity; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume 1; FVC, forced vital capacity; eGFR, estimated glomerular filtration rate; ACR, urinary albumin creatinine ratio; K-L grading scale, Kellgren−Lawrence grading scale; OA, osteoarthritis.

Physician-diagnosed diseases were defined according to self-reported medical history; most diseases according to the response to "diagnosed by a physician" of the health questionnaire, whereas both the current asthma and current peptic ulcer according to the response to "currently having the disease".

Statistical analysis and computation of disability-weights and YLDs {#sec007}
-------------------------------------------------------------------

Statistical analyses were performed with SPSS (version 22.0). Since the KCDC conducted the KNHANES using a complex survey design, we used SPSS Complex Samples modules to produce reliable point estimates and robust standard errors.

We computed YLDs as follows. First, we estimated the prevalence of each condition in every 2 × 2 age−sex group, arranged according to an age cutoff of 60 years and sex, as well as in the total population. Composite sample weights were introduced separately in each of the analyses to provide representative estimates of the Korean population. We calculated a total of nine composite sample weights by multiplying the survey sample weights by the year weights, according to KCDC's guidebook. The survey sample weight for each examination was computed using the sampling rate, response rate, and age−sex proportion of the Korean population. The year weight for each examination was determined by the number of households that participated in that year's examination.

Second, a general linear model was used to test the effect of each condition on the EQ-5D index, introducing the composite sample weight. Each adjusted mean difference from the reference group was computed using the estimated marginal means of the EQ-5D index; these were estimated as the mean value, averaged over all cells generated by the age (and sex for the analysis of the total population) category, after subdividing age into seven 10-year-width categories, from 20−29 years through to 70−79 years, as well as ≥ 80 years. For comparison, all other subjects without each condition served as the reference group. The differences in these age (and sex)-adjusted mean scores between the condition and reference groups were obtained for each of the 2 × 2 age−sex groups, as well as for the total population. As in the GBD 2010 and GHE \[[@pone.0172001.ref002],[@pone.0172001.ref003]\], it was assumed that the conditions co-occurred independently of each other within the age (and sex) category. However, for osteoarthritis and back pain (as well as caries and periodontitis), which were most prevalent and which were substantially correlated with each other, both conditions were introduced into the model together, to adjust for the effect of dependence. If the two-tailed *P* value exceeded 0.10 (one-tailed *P* value \> 0.05), the value of the adjusted mean difference was excluded from further analyses.

Third, the "adjusted mean difference of the EQ-5D index" was used to establish a condition-specific disability-weight. To estimate the comorbidity-adjusted effect of each condition on disability ("*condition specific DW*"), the disability-weight that included the condition of interest ("*combined DW*") was compared with the disability-weight that excluded the condition of interest ("*comorbid DW*"). Our approach was comparable to that of the GBD 2010 and GHE. Assuming that comorbid conditions change the quantitative score for the health-related quality of life multiplicatively rather than additively, $$1 - \mspace{9mu}\left( {comorbid\ DW} \right) \times \left( {1 - condition\ specific\ DW} \right) = \left( {1 - combined\ DW} \right)$$ $$2 - \mspace{9mu}\left( {1 - comorbid\ DW} \right) - \left( {1 - combined\ DW} \right) = condition\ specific\ DW \times \left( 1 - comorbid\ DW \right)$$

Assuming that comorbidities were independently distributed in the condition and reference groups within the age (and sex) category, the value of "1 -- *comorbid DW*" was replaced with the estimated "marginal mean of EQ-5D index in the reference group", and the value of "1 -- *combined DW*" was replaced with the "marginal mean in the group with the condition of interest".

We computed YLDs as the prevalence of each condition multiplied by the condition's disability-weight; this prevalence-based method had also been used in both the GBD 2010 and GHE: $$3 - \mspace{9mu} YLD = prevalence \times DW$$ $$4 - \mspace{9mu} comorbidity\ corrected\ condition\ specific\ YLD = combined\ YLD - comorbid\ YLD = prevalence \times \left( combined\ DW - comorbid\ DW \right)$$

The value of "*combined DW -- comorbid DW*" was replaced with the "adjusted mean difference of the EQ-5D index" between the condition and reference groups in our study. The same value had been calculated from "*condition specific DW* × (1 -- *comorbid DW*)" in the GBD 2010 and GHE \[[@pone.0172001.ref002],[@pone.0172001.ref003]\].

All-cause YLDs were estimated as the number of the population multiplied by the mean score of the combined disability-weight (= "1 -- *mean score of EQ*5*D index*").

We used the Korean population count released by Statistics Korea for 2012 in computing YLDs. Our YLDs were then compared with those of the WHO GHE 2014, the WHO's most recent update of the GHE for 2012.

Results {#sec008}
=======

Subject characteristics and EQ-5D index {#sec009}
---------------------------------------

The unweighted/weighted mean age of the study population was 50.4/45.6 years, and 57.8%/50.7% were female. The mean score of unweighted EQ-5D index of the study sample was 0.930, and the mean score of weighted EQ-5D index for the Korean population was 0.945. The mean score of the EQ-5D index decreased with age, and the age-related decrease in EQ-5D was more marked in females ([Fig 2](#pone.0172001.g002){ref-type="fig"}).

![EQ-5D index according to age and sex.](pone.0172001.g002){#pone.0172001.g002}

Prevalence and modified disability-weight {#sec010}
-----------------------------------------

[Table 3](#pone.0172001.t003){ref-type="table"} shows the prevalence rates and the modified condition-specific disability-weights for noncommunicable diseases and injuries. Diabetes, alcohol-use disorders, hearing impairment, chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), osteoarthritis, back pain, and periodontitis were common conditions, with a prevalence ≥ 5%. Iron-deficiency anemia was most prevalent in young females. Depression was more prevalent in females than in males. Alcohol-use disorders, road injury, other mechanical injuries, other unintentional injuries, and violence were most prevalent in young males. The prevalence rates of diabetes, visual/hearing impairment, ischemic heart disease, stroke, COPD, CKD, osteoarthritis, back pain, periodontitis, and edentulism were markedly higher in old than in young people. Osteoarthritis and back pain were very common in old females. Dental caries was common in all of the age−sex groups.

10.1371/journal.pone.0172001.t003

###### The prevalence rates and the modified disability weights for noncommunicable diseases and injuries.
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                                                           Prevalence estimate, %   Disability weight (SE)   *P*[^a^](#t003fn002){ref-type="table-fn"}   Disability weight (SE)   *P*[^a^](#t003fn002){ref-type="table-fn"}   Disability weight (SE)   *P*[^a^](#t003fn002){ref-type="table-fn"}   Disability weight (SE)   *P*[^a^](#t003fn002){ref-type="table-fn"}   Disability weight (SE)   *P*[^a^](#t003fn002){ref-type="table-fn"}                                                                          
  ----- -------------------------------------------------- ------------------------ ------------------------ ------------------------------------------- ------------------------ ------------------------------------------- ------------------------ ------------------------------------------- ------------------------ ------------------------------------------- ------------------------ ------------------------------------------- -------- --------- ------ -------- --------- ------ -------- --------- ------
  0     All Causes                                                                                                                                                                                                            0.055                    (0.001)                                                              0.026                                       (0.001)                                                              0.043    (0.001)          0.095    (0.002)          0.171    (0.003)   
  58    Iron-deficiency anemia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
        Mild                                               2.18%                    0.20%                    4.81%                                       0.98%                    1.18%                                       -0.009                   (0.003)                                     .003                     0.014                                       (0.016)                  .402                                        -0.005   (0.003)   .060   -0.014   (0.021)   .506   0.011    (0.026)   .684
        Moderate                                           2.44%                    0.19%                    4.90%                                       1.13%                    3.25%                                       0.008                    (0.005)                                     .146                     0.042                                       (0.020)                  .032                                        0.005    (0.005)   .374   0.103    (0.041)   .012   0.014    (0.015)   .362
        Severe                                             0.19%                    0.03%                    0.36%                                       0.12%                    0.21%                                       0.015                    (0.014)                                     .296                     -0.007                                      (0.021)                  .740                                        0.007    (0.016)   .658   0.115    (0.066)   .083   0.066    (0.048)   .173
  64    Stomach cancer                                     0.54%                    0.24%                    0.21%                                       2.55%                    1.16%                                       -0.001                   (0.009)                                     .908                     -0.013                                      (0.010)                  .207                                        0.013    (0.020)   .523   0.009    (0.015)   .559   0.005    (0.021)   .793
  65    Colon cancers                                      0.30%                    0.18%                    0.06%                                       1.49%                    0.66%                                       0.011                    (0.014)                                     .430                     -0.009                                      (0.012)                  .449                                        -0.011   (0.028)   .701   0.045    (0.026)   .087   0.003    (0.030)   .915
  66    Liver cancer                                       0.10%                    0.11%                    0.02%                                       0.42%                    0.07%                                       0.008                    (0.022)                                     .720                     -0.024                                      (0.009)                  .005                                        0.150    (0.039)   .000   0.025    (0.049)   .610   0.019    (0.027)   .467
  68    Lung cancers                                       0.07%                    0.03%                    0.02%                                       0.43%                    0.08%                                       0.041                    (0.035)                                     .249                     0.061                                       (0.024)                  .013                                        -0.031   (0.036)   .391   0.098    (0.059)   .099   -0.084   (0.028)   .003
  70    Breast cancer                                      0.35%                    0.00%                    0.58%                                       0.00%                    1.09%                                       0.035                    (0.015)                                     .022                                                                                                                                      0.031    (0.015)   .039                             0.028    (0.033)   .388
  71    Cervix cancer                                      0.37%                    0.00%                    0.49%                                       0.00%                    1.55%                                       -0.004                   (0.009)                                     .640                                                                                                                                      0.005    (0.009)   .605                             -0.028   (0.015)   .071
  78    Other malignancy                                   1.11%                    0.43%                    1.23%                                       2.65%                    1.89%                                       0.002                    (0.006)                                     .689                     -0.004                                      (0.009)                  .693                                        0.004    (0.007)   .557   0.010    (0.015)   .507   0.010    (0.019)   .604
  80    Diabetes mellitus                                  8.71%                    7.09%                    4.11%                                       23.00%                   20.73%                                      0.020                    (0.003)                                     .000                     0.015                                       (0.004)                  .000                                        0.021    (0.006)   .000   0.026    (0.006)   .000   0.021    (0.007)   .002
  83    Depression                                         3.69%                    1.71%                    5.01%                                       2.49%                    7.07%                                       0.072                    (0.005)                                     .000                     0.100                                       (0.015)                  .000                                        0.065    (0.005)   .000   0.075    (0.016)   .000   0.060    (0.009)   .000
  86    Alcohol use disorders                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
        Harmful drinking behavior                          6.81%                    12.11%                   2.12%                                       6.69%                    0.26%                                       0.004                    (0.002)                                     .094                     0.002                                       (0.002)                  .369                                        0.015    (0.007)   .034   -0.011   (0.009)   .262   -0.009   (0.050)   .854
        Alcohol dependence                                 6.91%                    11.95%                   2.40%                                       7.22%                    0.43%                                       0.017                    (0.003)                                     .000                     0.013                                       (0.003)                  .000                                        0.033    (0.010)   .001   0.016    (0.010)   .099   0.056    (0.039)   .150
  103   Glaucoma with visual impairment                    0.21%                    0.11%                    0.06%                                       0.55%                    0.79%                                       0.028                    (0.030)                                     .338                     0.040                                       (0.022)                  .074                                        0.010    (0.023)   .672   0.061    (0.046)   .192   0.007    (0.065)   .915
  104   Cataracts with visual impairment                   1.28%                    0.31%                    0.22%                                       4.26%                    6.21%                                       0.059                    (0.012)                                     .000                     0.051                                       (0.016)                  .001                                        0.050    (0.023)   .028   0.093    (0.023)   .000   0.039    (0.017)   .026
  105   Uncorrected refractive errors                      3.85%                    2.47%                    4.26%                                       4.10%                    7.27%                                       0.011                    (0.005)                                     .015                     0.022                                       (0.007)                  .003                                        0.009    (0.006)   .097   -0.019   (0.015)   .201   0.014    (0.014)   .312
  106   Macular degeneration with visual impairment        0.17%                    0.03%                    0.01%                                       0.88%                    0.86%                                       0.079                    (0.038)                                     .039                     -0.043                                      (0.003)                  .000                                        0.015    (0.002)   .000   0.100    (0.067)   .137   0.087    (0.045)   .053
  107   Diabetic retinopathy with visual impairment        0.07%                    0.01%                    0.03%                                       0.23%                    0.37%                                       0.071                    (0.032)                                     .027                     0.086                                       (0.002)                  .000                                        -0.021   (0.038)   .587   0.124    (0.074)   .093   0.060    (0.038)   .111
  108   Disabling hearing impairment                       6.92%                    3.36%                    2.68%                                       21.42%                   18.69%                                      0.014                    (0.005)                                     .002                     0.008                                       (0.007)                  .246                                        0.001    (0.006)   .875   0.032    (0.008)   .000   0.018    (0.011)   .097
  113   Ischemic heart disease                             1.80%                    0.87%                    0.58%                                       6.71%                    5.43%                                       0.052                    (0.007)                                     .000                     0.057                                       (0.018)                  .000                                        0.041    (0.011)   .000   0.040    (0.011)   .001   0.068    (0.013)   .000
  114   Stroke                                             1.54%                    0.68%                    0.42%                                       6.31%                    4.69%                                       0.102                    (0.009)                                     .000                     0.114                                       (0.022)                  .000                                        0.075    (0.023)   .001   0.117    (0.013)   .000   0.096    (0.016)   .000
  118   COPD, age ≥40 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
        Mild                                               6.23%                    4.38%                    1.11%                                       20.56%                   7.31%                                       -0.003                   (0.005)                                     .502                     0.007                                       (0.007)                  .336                                        -0.004   (0.011)   .686   0.000    (0.007)   .976   0.013    (0.013)   .328
        Moderate                                           6.55%                    5.59%                    1.75%                                       19.93%                   6.23%                                       0.003                    (0.004)                                     .455                     0.011                                       (0.007)                  .124                                        0.026    (0.010)   .010   0.009    (0.006)   .151   0.003    (0.015)   .863
        Severe                                             0.68%                    0.50%                    0.21%                                       2.48%                    0.47%                                       0.030                    (0.015)                                     .043                     0.062                                       (0.029)                  .033                                        0.092    (0.072)   .202   0.034    (0.017)   .042   0.002    (0.041)   .969
  119   Asthma                                             1.57%                    0.94%                    1.10%                                       2.88%                    4.37%                                       0.061                    (0.007)                                     .000                     0.037                                       (0.013)                  .004                                        0.044    (0.013)   .001   0.076    (0.016)   .000   0.083    (0.016)   .000
  122   Peptic ulcer, gastric or duodenal                  1.05%                    0.82%                    0.81%                                       1.73%                    2.31%                                       0.077                    (0.013)                                     .000                     0.061                                       (0.023)                  .007                                        0.056    (0.019)   .003   0.073    (0.043)   .092   0.119    (0.030)   .000
  123   Cirrhosis of the liver                             0.23%                    0.22%                    0.10%                                       0.68%                    0.33%                                       0.012                    (0.011)                                     .278                     0.009                                       (0.017)                  .618                                        0.021    (0.028)   .464   0.033    (0.024)   .162   -0.003   (0.022)   .890
  127   Chronic kidney disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
        Moderately increased risk                          7.20%                    4.08%                    4.72%                                       17.23%                   18.46%                                      0.010                    (0.004)                                     .011                     0.010                                       (0.007)                  .132                                        0.002    (0.005)   .758   0.030    (0.010)   .002   0.005    (0.009)   .582
        High risk                                          1.33%                    0.63%                    0.51%                                       4.97%                    3.57%                                       0.019                    (0.010)                                     .072                     0.019                                       (0.019)                  .315                                        0.029    (0.018)   .103   0.014    (0.013)   .285   0.034    (0.025)   .179
        Very high risk                                     0.49%                    0.25%                    0.20%                                       1.58%                    1.45%                                       0.074                    (0.018)                                     .000                     0.092                                       (0.042)                  .030                                        0.028    (0.017)   .112   0.079    (0.027)   .003   0.088    (0.035)   .011
  133   Atopic dermatitis                                  2.79%                    3.15%                    3.33%                                       1.16%                    0.94%                                       0.013                    (0.003)                                     .000                     0.010                                       (0.004)                  .012                                        0.009    (0.004)   .037   0.047    (0.021)   .028   0.086    (0.032)   .007
  135   Rheumatoid arthritis                               1.66%                    0.65%                    1.56%                                       1.67%                    5.56%                                       0.069                    (0.008)                                     .000                     0.060                                       (0.014)                  .000                                        0.055    (0.011)   .000   0.085    (0.023)   .000   0.072    (0.014)   .000
  136   OA, age ≥50 years                                  12.84%                   2.43%                    7.65%                                       8.16%                    28.86%                                      0.099                    (0.006)                                     .000                     0.070                                       (0.020)                  .000                                        0.077    (0.011)   .000   0.102    (0.012)   .000   0.105    (0.009)   .000
  138   Back pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
        Back pain with radiographic OA, age ≥50 years      10.37%                   2.66%                    4.77%                                       7.80%                    22.94%                                      0.125                    (0.008)                                     .000                     0.132                                       (0.033)                  .000                                        0.104    (0.013)   .000   0.122    (0.014)   .000   0.129    (0.010)   .000
        Back pain without radiographic OA, age ≥50 years   12.39%                   7.39%                    14.88%                                      8.82%                    17.01%                                      0.091                    (0.006)                                     .000                     0.064                                       (0.012)                  .000                                        0.078    (0.009)   .000   0.123    (0.014)   .000   0.099    (0.009)   .000
        Back pain, age 20−49 years                         8.53%                    6.45%                    10.73%                                                                                                           0.054                    (0.005)                                     .000                     0.050                                       (0.008)                  .000                                        0.056    (0.006)   .000                                                
  148   Dental caries                                      4.94%                    5.05%                    3.88%                                       7.44%                    6.13%                                       0.022                    (0.005)                                     .000                     0.012                                       (0.007)                  .075                                        0.023    (0.008)   .002   0.037    (0.018)   .035   0.047    (0.021)   .026
  149   Periodontal disease                                5.34%                    5.36%                    2.51%                                       11.98%                   10.42%                                      0.033                    (0.006)                                     .000                     0.013                                       (0.007)                  .058                                        0.033    (0.010)   .001   0.033    (0.016)   .039   0.064    (0.018)   .000
  150   Edentulism                                         2.20%                    0.36%                    0.17%                                       8.76%                    10.17%                                      0.027                    (0.007)                                     .000                     -0.002                                      (0.013)                  .900                                        0.082    (0.063)   .191   0.039    (0.011)   .001   0.020    (0.010)   .055
  153   Road injury                                        2.30%                    2.98%                    1.95%                                       2.03%                    1.27%                                       0.017                    (0.004)                                     .000                     0.010                                       (0.005)                  .034                                        0.016    (0.005)   .002   0.054    (0.027)   .047   0.028    (0.021)   .168
  154   Poisonings                                         0.09%                    0.10%                    0.11%                                       0.03%                    0.03%                                       0.004                    (0.014)                                     .750                     -0.006                                      (0.009)                  .517                                        0.003    (0.025)   .891   0.010    (0.063)   .874   0.131    (0.035)   .000
  155   Falls                                              2.25%                    2.08%                    1.74%                                       2.35%                    4.54%                                       0.048                    (0.005)                                     .000                     0.035                                       (0.007)                  .000                                        0.030    (0.007)   .000   0.065    (0.018)   .000   0.078    (0.017)   .000
  156   Fire and heat injury                               0.10%                    0.09%                    0.12%                                       0.04%                    0.05%                                       0.019                    (0.015)                                     .200                     0.006                                       (0.016)                  .724                                        0.015    (0.018)   .404   0.098    (0.081)   .228   0.109    (0.132)   .409
  157   Drowning                                           0.00%                    0.00%                    0.01%                                       0.00%                    0.01%                                       -0.013                   (0.056)                                     .817                                                                                                                                      0.058    (0.001)   .000                             -0.199   (0.004)   .000
  158   Injuries from other mechanical forces              1.71%                    2.41%                    1.18%                                       1.30%                    1.39%                                       0.026                    (0.005)                                     .000                     0.020                                       (0.005)                  .000                                        0.014    (0.010)   .160   0.012    (0.015)   .432   0.087    (0.031)   .005
  159   Other unintentional injuries                       0.78%                    0.83%                    0.79%                                       0.59%                    0.74%                                       0.020                    (0.008)                                     .009                     0.019                                       (0.013)                  .127                                        0.004    (0.008)   .601   0.071    (0.043)   .096   0.042    (0.027)   .122
  161   Self-harm                                          0.03%                    0.01%                    0.04%                                       0.04%                    0.05%                                       0.096                    (0.050)                                     .053                     0.065                                       (0.059)                  .272                                        0.051    (0.038)   .173   0.583    (0.166)   .000   -0.013   (0.094)   .891
  162   Violence                                           0.09%                    0.10%                    0.09%                                       0.06%                    0.07%                                       0.083                    (0.029)                                     .004                     0.085                                       (0.036)                  .020                                        0.082    (0.056)   .146   0.131    (0.034)   .000   0.049    (0.106)   .646

Abbreviations: GHE, Global Health Estimates; KNHANES, Korea National Health and Nutrition Examination Survey; SE, standard error; OA, osteoarthritis.

^a^ If the two-tailed P value exceeded 0.10 (one-tailed P value \> 0.05), the value of the disability weight was excluded from further analyses.

The modified disability-weights for visual impairments, stroke, osteoarthritis, back pain, and self-harm were distinctly larger than those for other conditions. When the disability-weight for each condition was compared between the age−sex groups, stroke, asthma, atopic dermatitis, rheumatoid arthritis, osteoarthritis, back pain, caries, periodontitis, falls, and other mechanical injuries had larger disability-weights in old than in young people. The disability-weights for iron-deficiency anemia and lung cancers were significant only in males. Diabetes had a relatively small disability-weight in young males, as compared to other age−sex groups.

All-cause and condition-specific YLD {#sec011}
------------------------------------

All-cause YLDs in 39044 thousand adults aged ≥20 years were 2165 thousand years. The combined YLDs (the sum of each condition-specific YLD) from noncommunicable diseases and injuries were similar to all-cause YLDs in old males, whereas those in young females accounted for about 50% of all-cause YLDs ([Table 4](#pone.0172001.t004){ref-type="table"}).

10.1371/journal.pone.0172001.t004

###### Condition-specific YLDs for noncommunicable diseases and injuries.

![](pone.0172001.t004){#pone.0172001.t004g}

                                                           YLDs of total[^b^](#t004fn003){ref-type="table-fn"}   Aggregate of YLDs[^c^](#t004fn004){ref-type="table-fn"}   YLDs         YLDs         YLDs        YLDs
  ----- -------------------------------------------------- ----------------------------------------------------- --------------------------------------------------------- ------------ ------------ ----------- -----------
        Population                                         39,044,074                                            39,044,074                                                15,737,018   15,041,580   3,572,458   4,693,018
  0     All Causes                                         2,165,093                                             2,200,800                                                 415,560      646,050      338,918     800,272
        Sum[^a^](#t004fn002){ref-type="table-fn"}          1,516,713                                             1,535,266                                                 268,498      333,101      323,398     610,269
  58    Iron-deficiency anemia                                                                                                                                                                                   
        Mild                                               -7,928                                                -3,805                                                    0            -3,805       0           0
        Moderate                                           0                                                     5,451                                                     1,275        0            4,176       0
        Severe                                             0                                                     490                                                       0            0            490         0
  64    Stomach cancer                                     0                                                     0                                                         0            0            0           0
  65    Colon cancers                                      0                                                     2,413                                                     0            0            2,413       0
  66    Liver cancer                                       0                                                     118                                                       -412         530          0           0
  68    Lung cancers                                       0                                                     1,537                                                     317          0            1,518       -299
  70    Breast cancer                                      4,787                                                 2,719                                                     0            2,719        0           0
  71    Cervix cancer                                      0                                                     -2,036                                                    0            0            0           -2,036
  78    Other malignancy                                   0                                                     0                                                         0            0            0           0
  80    Diabetes mellitus                                  68,662                                                72,413                                                    17,280       13,140       21,686      20,306
  83    Depression                                         103,900                                               102,035                                                   26,881       48,610       6,688       19,856
  86    Alcohol use disorders                                                                                                                                                                                    
        Harmful drinking behavior                          9,672                                                 4,778                                                     0            4,778        0           0
        Alcohol dependence                                 44,928                                                40,050                                                    23,986       11,863       4,201       0
  103   Glaucoma with visual impairment                    0                                                     696                                                       696          0            0           0
  104   Cataracts with visual impairment                   29,424                                                29,664                                                    2,459        1,651        14,206      11,348
  105   Uncorrected refractive errors                      17,174                                                14,598                                                    8,515        6,083        0           0
  106   Macular degeneration with visual impairment        5,322                                                 3,374                                                     -174         25           0           3,523
  107   Diabetic retinopathy with visual impairment        2,068                                                 1,104                                                     90           0            1,013       0
  108   Disabling hearing impairment                       37,725                                                39,720                                                    0            0            24,187      15,532
  113   Ischemic heart disease                             36,155                                                38,123                                                    7,818        3,567        9,526       17,212
  114   Stroke                                             61,295                                                64,633                                                    12,254       4,807        26,332      21,240
  118   COPD, age ≥40 years                                                                                                                                                                                      
        Mild                                               0                                                     0                                                         0            0            0           0
        Moderate                                           0                                                     3,605                                                     0            3,605        0           0
        Severe                                             4,937                                                 5,469                                                     2,451        0            3,019       0
  119   Asthma                                             37,361                                                37,473                                                    5,430        7,208        7,796       17,040
  122   Peptic ulcer, gastric or duodenal                  31,451                                                32,141                                                    7,862        6,870        4,481       12,929
  123   Cirrhosis of the liver                             0                                                     0                                                         0            0            0           0
  127   Chronic kidney disease                                                                                                                                                                                   
        Moderately increased risk                          28,502                                                18,406                                                    0            0            18,406      0
        High risk                                          9,799                                                 0                                                         0            0            0           0
        Very high risk                                     14,268                                                14,067                                                    3,645        0            4,449       5,973
  133   Atopic dermatitis                                  14,554                                                14,933                                                    4,780        4,427        1,949       3,777
  135   Rheumatoid arthritis                               45,059                                                42,953                                                    6,153        13,035       5,043       18,721
  136   OA, age ≥50 years                                  199,650                                               200,751                                                   6,320        21,937       29,856      142,638
  138   Back pain                                                                                                                                                                                                
        Back pain with radiographic OA, age ≥50 years      202,907                                               204,031                                                   13,062       18,342       33,910      138,717
        Back pain without radiographic OA, age ≥50 years   177,350                                               178,841                                                   17,603       43,149       38,853      79,236
        Back pain, age 20−49 years                         107,488                                               107,348                                                   38,820       68,528       0           0
  148   Dental caries                                      42,614                                                46,429                                                    9,441        13,383       9,958       13,647
  149   Periodontal disease                                68,075                                                69,465                                                    11,025       12,615       14,295      31,530
  150   Edentulism                                         23,579                                                21,729                                                    0            0            12,200      9,530
  153   Road injury                                        15,523                                                13,584                                                    4,807        4,825        3,951       0
  154   Poisonings                                         0                                                     187                                                       0            0            0           187
  155   Falls                                              42,504                                                41,273                                                    11,377       7,781        5,416       16,699
  156   Fire and heat injury                               0                                                     0                                                         0            0            0           0
  157   Drowning                                           0                                                     -24                                                       0            58           0           -81
  158   Injuries from other mechanical forces              17,266                                                13,106                                                    7,432        0            0           5,675
  159   Other unintentional injuries                       6,091                                                 1,500                                                     0            0            1,500       0
  161   Self-harm                                          1,149                                                 746                                                       0            0            746         0
  162   Violence                                           2,818                                                 1,572                                                     1,296        0            276         0

Abbreviations: YLDs, years lived with disability; GHE, Global Health Estimates; KNHANES, Korea National Health and Nutrition Examination Survey; COPD, chronic obstructive pulmonary disease; OA, osteoarthritis

^a^ The combined YLDs from all the conditions investigated in this study.

^b^ The condition-specific YLDs calculated using the prevalence and disability weight obtained in the total population.

^c^ The aggregate of condition-specific YLDs of each age-sex group.

YLDs due to back pain and osteoarthritis were about 487745 and 199650, respectively, and were largest among all the condition-specific YLDs, particularly in old females. Additionally, depression, diabetes, stroke, and periodontitis had YLDs \> 50000 years.

The aggregate of condition-specific YLDs for each age−sex group was similar to the condition-specific YLDs calculated using the prevalence and disability-weight determined in the total population.

Comparison with WHO estimates {#sec012}
-----------------------------

[Table 5](#pone.0172001.t005){ref-type="table"} shows the estimates converted to YLDs per 100000 people. The magnitude of the combined YLDs in our study was less than the WHO estimates. The ratio difference between our combined YLDs and the WHO YLDs was largest in young males, whereas it was minimal in old females. Many condition-specific YLDs in our study were less than those of the WHO estimates. The YLDs for iron-deficiency anemia, malignancies, diabetes, depression, alcohol-use disorders, visual/hearing impairment, ischemic heart disease, COPD, and injuries were substantially smaller than those of the GHE. However, the YLDs for stroke, peptic ulcer, osteoarthritis, back pain, caries, and periodontitis were larger than those of the WHO estimates. Particularly, the YLDs for back pain and osteoarthritis in old females were markedly larger than those of the WHO estimates.

10.1371/journal.pone.0172001.t005

###### Comparisons of YLDs per 100000 people between the current study and the WHO's global and regional estimates.

![](pone.0172001.t005){#pone.0172001.t005g}

                                                                  Global    Study     ROK       Global    Study     ROK       Global    Study     ROK                                                         
  --------- ----------------------------------------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
            Population                                            100,000   100,000   100,000   100,000   100,000   100,000   100,000   100,000   100,000   100,000   100,000   100,000   100,000   100,000   100,000
  0         All Causes                                            12,166    5,637     11,062    10,176    10,835    2,641     4,295     9,431     9,674     21,053    21,273    9,487     17,052    16,702    17,716
            Sum[^a^](#t005fn002){ref-type="table-fn"}             7,507     3,810               6,183     5,979     1,604     2,126                         15,200    15,224    8,749     12,847              
            Sum[^b^](#t005fn003){ref-type="table-fn"}             6,232     3,192     5,914     5,527     5,345     1,354     1,901     5,498     4,549     10,611    10,459    6,583     10,912    9,735     9,395
  58        Iron-deficiency anemia                                341       5         61        196       510       8         -25       68        48        237       329       131       0         101       50
  64        Stomach cancer                                        5         0         15        2         1         0         0         7         4         29        14        0         0         82        32
  65        Colon and rectum cancers                              11        6         22        4         3         0         0         9         6         63        46        68        0         105       65
  66        Liver cancer                                          3         0         8         2         1         -3        4         6         1         15        7         0         0         43        15
  68        Trachea, bronchus, lung cancers                       7         4         10        3         1         2         0         4         2         51        18        42        -6        69        22
  70        Breast cancer                                         18        7         23        0         18        0         18        0         27        0         124       0         0                   112
  71        Cervix uteri cancer                                   2         -5        2         0         4         0         0         0         4         0         8         0         -43                 6
  78        Other malignant neoplasms                             12        0         16        7         6         0         0         7         9         50        32        0         0         56        45
  80        Diabetes mellitus                                     420       185       629       289       286       110       87        441       448       1,121     1,143     607       433       1,345     1,424
  83        Unipolar depressive disorders/Depression              1,315     261       832       1,020     1,662     171       323       652       1,042     883       1,465     187       423       583       939
  86        Alcohol-use disorders                                 527       115       837       974       173       152       111       1,561     348       435       82        118       0         563       120
  103       Glaucoma                                              24        2                   5         6         4         0                             110       141       0         0                   
  104       Cataracts                                             133       76                  31        49        16        11                            492       756       398       242                 
  105       Refractive errors/Uncorrected                         253       37                  104       129       54        40                            902       1,066     0         0                   
  106       Macular degeneration                                  27        9                   2         3         -1        0                             124       194       0         75                  
  107       Other vision loss/Diabetic retinopathy                138       3                   62        70        1         0                             513       534       28        0                   
  108       Other hearing loss/Disabling hearing impairment       419       102                 234       156       0         0                             1,870     1,427     677       331                 
  113       Ischemic heart disease                                177       98        186       104       82        50        24        107       96        703       562       267       367       564       506
  114       Stroke                                                88        166       130       35        27        78        32        50        34        425       375       737       453       538       453
  118       COPD/age ≥ 40 years                                   567       23        181       476       410       16        24        131       112       1,276     1,200     85        0         441       414
  119       Asthma                                                156       96        132       145       161       35        48        121       128       163       186       218       363       156       170
  122       Peptic ulcer disease                                  6         82        17        7         5         50        46        17        14        11        7         125       275       35        19
  123       Cirrhosis of the liver                                12        0         11        12        7         0         0         13        5         34        21        0         0         30        13
  127       Kidney diseases/Chronic kidney disease                79        83        110       40        49        23        0         58        75        277       251       640       127       281       297
  133       Skin diseases/Atopic dermatitis                       231       38        232       192       216       30        29        187       210       380       370       55        80        368       370
  135       Rheumatoid arthritis                                  75        110       150       23        86        39        87        50        171       77        276       141       399       130       456
  136       Osteoarthritis/age ≥ 50 years                         347       514       402       170       288       40        146       198       333       739       1,201     836       3,039     714       1,159
  138       Back and neck pain/Back pain                          974       1,256     1,070     906       859       442       864       964       964       1,530     1,413     2,037     4,644     1,532     1,484
  148       Dental caries                                         79        119                 82        85        60        89                            52        53        279       291                 
  149       Periodontal disease                                   108       178                 100       94        70        84                            177       161       400       672                 
  150       Edentulism                                            95        56                  36        42        0         0                             350       434       341       203                 
  153       Road injury                                           252       35        208       337       169       31        32        273       147       354       145       111       0         307       113
  154       Poisonings                                            8         0         1         10        5         0         0         2         1         17        7         0         4         2         1
  155       Falls                                                 380       106       450       286       185       72        52        344       220       1,347     998       152       356       1,352     975
  156       Fire, heat, and hot substances                        25        0         16        29        18        0         0         19        11        42        22        0         0         29        15
  157       Drowning                                              5         0         2         6         3         0         0         2         1         13        6         0         -2        6         2
  158+159   Other unintentional injuries including other forces   152       2         135       189       90        0         0         167       76        307       139       21        0         281       115
  161       Self-harm                                             8         4         3         10        6         8         0         4         2         11        4         8         0         6         1
  162       Interpersonal violence                                30        0         21        52        14        0         0         37        10        22        6         0         0         15        4

Abbreviations: YLDs, years lived with disability; GHE, Global Health Estimates; KNHANES, Korea National Health and Nutrition Examination Survey; ROK, Republic of Korea; COPD, chronic obstructive pulmonary disease.

^a^ The combined YLDs from all the conditions investigated in this study.

^b^ The combined YLDs from all the investigated conditions available in regional estimates.

^c^ Age 20−59 years in this study or age 15−59 years in WHO's global and regional estimates.

Rank and percentage of YLD {#sec013}
--------------------------

The overall rank and the percentage of YLDs in this study differed from the WHO estimates ([Table 6](#pone.0172001.t006){ref-type="table"}). Alcohol-use disorders, COPD, and injuries ranked lower in our study, and depression, diabetes, alcohol-use disorders, COPD, and injuries accounted for a reduced percentage of all-cause YLDs, than in the WHO estimates. In contrast, osteoarthritis, stroke, and peptic ulcer ranked higher and accounted for a greater percentage of all-cause YLDs than in the WHO estimates.

10.1371/journal.pone.0172001.t006

###### The ranks of condition-specific YLDs and the percentage of all-cause YLDs accounted for by each condition-specific YLD

![](pone.0172001.t006){#pone.0172001.t006g}

                                                                  \% YLD   Rank   \% YLD   Rank    \% YLD   \% YLD   \% YLD                                                                                           
  --------- ----------------------------------------------------- -------- ------ -------- ------- -------- -------- -------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- -------
  0         All Causes                                            100%                     100%                      100%     100%    100%    100%    100%    100%    100%    100%    100%    100%    100%    100%    100%
            Sum[^a^](#t006fn002){ref-type="table-fn"}             61.7%                    67.6%                              60.8%   60.8%           55.2%   49.5%           72.2%   92.2%           71.6%   75.3%   
            Sum[^b^](#t006fn003){ref-type="table-fn"}             51.2%                    56.6%                     53.5%    54.3%   51.3%   58.3%   49.3%   44.3%   47.0%   50.4%   69.4%   58.3%   49.2%   64.0%   53.0%
  138       Back and neck pain/Back pain                          8.0%     2      1        22.3%   1        1        9.7%     8.9%    16.7%   10.2%   7.9%    20.1%   10.0%   7.3%    21.5%   9.2%    6.6%    27.2%   8.4%
  136       Osteoarthritis/age ≥ 50 years                         2.9%     8      2        9.1%    2        6        3.6%     1.7%    1.5%    2.1%    2.7%    3.4%    3.4%    3.5%    8.8%    4.3%    5.6%    17.8%   6.5%
  83        Unipolar depressive disorders/Depression              10.8%    1      3        4.6%    3        3        7.5%     10.0%   6.5%    6.9%    15.3%   7.5%    10.8%   4.2%    2.0%    3.5%    6.9%    2.5%    5.3%
  80        Diabetes mellitus                                     3.4%     5      4        3.3%    4        4        5.7%     2.8%    4.2%    4.7%    2.6%    2.0%    4.6%    5.3%    6.4%    8.1%    5.4%    2.5%    8.0%
  149       Periodontal disease                                   0.9%     18     5        3.2%                               1.0%    2.7%            0.9%    2.0%            0.8%    4.2%            0.8%    3.9%    
  114       Stroke                                                0.7%     20     6        2.9%    5        14       1.2%     0.3%    2.9%    0.5%    0.2%    0.7%    0.4%    2.0%    7.8%    3.2%    1.8%    2.7%    2.6%
  148       Dental caries                                         0.6%     21     7        2.1%                               0.8%    2.3%            0.8%    2.1%            0.2%    2.9%            0.2%    1.7%    
  86        Alcohol-use disorders                                 4.3%     4      8        2.0%    6        2        7.6%     9.6%    5.8%    16.5%   1.6%    2.6%    3.6%    2.1%    1.2%    3.4%    0.4%    0.0%    0.7%
  135       Rheumatoid arthritis                                  0.6%     23     9        2.0%    7        11       1.4%     0.2%    1.5%    0.5%    0.8%    2.0%    1.8%    0.4%    1.5%    0.8%    1.3%    2.3%    2.6%
  155       Falls                                                 3.1%     7      10       1.9%    8        5        4.1%     2.8%    2.7%    3.6%    1.7%    1.2%    2.3%    6.4%    1.6%    8.1%    4.7%    2.1%    5.5%
  108       Other hearing loss/Disabling hearing impairment       3.4%     6      11       1.8%                               2.3%    0.0%            1.4%    0.0%            8.9%    7.1%            6.7%    1.9%    
  113       Ischemic heart disease                                1.5%     13     12       1.7%    9        9        1.7%     1.0%    1.9%    1.1%    0.8%    0.6%    1.0%    3.3%    2.8%    3.4%    2.6%    2.2%    2.9%
  119       Asthma                                                1.3%     14     13       1.7%    10       13       1.2%     1.4%    1.3%    1.3%    1.5%    1.1%    1.3%    0.8%    2.3%    0.9%    0.9%    2.1%    1.0%
  127       Kidney diseases/Chronic kidney disease                0.6%     22     14       1.5%    11       15       1.0%     0.4%    0.9%    0.6%    0.5%    0.0%    0.8%    1.3%    6.7%    1.7%    1.2%    0.7%    1.7%
  122       Peptic ulcer disease                                  0.1%     35     15       1.5%    12       20       0.2%     0.1%    1.9%    0.2%    0.0%    1.1%    0.1%    0.1%    1.3%    0.2%    0.0%    1.6%    0.1%
  104       Cataracts                                             1.1%     17     16       1.3%                               0.3%    0.6%            0.5%    0.3%            2.3%    4.2%            3.6%    1.4%    
  150       Edentulism                                            0.8%     19     17       1.0%                               0.4%    0.0%            0.4%    0.0%            1.7%    3.6%            2.0%    1.2%    
  133       Skin diseases/Atopic dermatitis                       1.9%     12     18       0.7%    13       7        2.1%     1.9%    1.2%    2.0%    2.0%    0.7%    2.2%    1.8%    0.6%    2.2%    1.7%    0.5%    2.1%
  105       Refractive errors/Uncorrected                         2.1%     10     19       0.7%                               1.0%    2.0%            1.2%    0.9%            4.3%    0.0%            5.0%    0.0%    
  153       Road injury                                           2.1%     11     20       0.6%    14       8        1.9%     3.3%    1.2%    2.9%    1.6%    0.7%    1.5%    1.7%    1.2%    1.8%    0.7%    0.0%    0.6%
  118       COPD/age ≥ 40 years                                   4.7%     3      21       0.4%    15       10       1.6%     4.7%    0.6%    1.4%    3.8%    0.6%    1.2%    6.1%    0.9%    2.6%    5.6%    0.0%    2.3%
  106       Macular degeneration                                  0.2%     25     22       0.2%                               0.0%    0.0%            0.0%    0.0%            0.6%    0.0%            0.9%    0.4%    
  70        Breast cancer                                         0.1%     28     23       0.1%    16       17       0.2%     0.0%    0.0%    0.0%    0.2%    0.4%    0.3%    0.0%    0.0%    0.0%    0.6%    0.0%    0.6%
  65        Colon and rectum cancers                              0.1%     31     24       0.1%    17       18       0.2%     0.0%    0.0%    0.1%    0.0%    0.0%    0.1%    0.3%    0.7%    0.6%    0.2%    0.0%    0.4%
  58        Iron-deficiency anemia                                2.8%     9      25       0.1%    18       16       0.6%     1.9%    0.3%    0.7%    4.7%    -0.6%   0.5%    1.1%    1.4%    0.6%    1.5%    0.0%    0.3%
  162       Interpersonal violence                                0.2%     24     26       0.1%    19       19       0.2%     0.5%    0.3%    0.4%    0.1%    0.0%    0.1%    0.1%    0.1%    0.1%    0.0%    0.0%    0.0%
  68        Trachea, bronchus, lung cancers                       0.1%     34     27       0.1%    20       25       0.1%     0.0%    0.1%    0.0%    0.0%    0.0%    0.0%    0.2%    0.4%    0.4%    0.1%    0.0%    0.1%
  107       Other vision loss/Diabetic retinopathy                1.1%     16     28       0.1%                               0.6%    0.0%            0.6%    0.0%            2.4%    0.3%            2.5%    0.0%    
  161       Self-harm                                             0.1%     33     29       0.0%    21       27       0.0%     0.1%    0.0%    0.0%    0.1%    0.0%    0.0%    0.1%    0.2%    0.0%    0.0%    0.0%    0.0%
  103       Glaucoma                                              0.2%     27     30       0.0%                               0.0%    0.2%            0.1%    0.0%            0.5%    0.0%            0.7%    0.0%    
  154       Poisonings                                            0.1%     32     31       0.0%    22       30       0.0%     0.1%    0.0%    0.0%    0.0%    0.0%    0.0%    0.1%    0.0%    0.0%    0.0%    0.0%    0.0%
  66        Liver cancer                                          0.0%     38     32       0.0%    23       26       0.1%     0.0%    -0.1%   0.1%    0.0%    0.1%    0.0%    0.1%    0.0%    0.3%    0.0%    0.0%    0.1%
  64        Stomach cancer                                        0.0%     37     33       0.0%    24       23       0.1%     0.0%    0.0%    0.1%    0.0%    0.0%    0.0%    0.1%    0.0%    0.5%    0.1%    0.0%    0.2%
  78        Other malignant neoplasms                             0.1%     30     34       0.0%    25       21       0.1%     0.1%    0.0%    0.1%    0.1%    0.0%    0.1%    0.2%    0.0%    0.3%    0.2%    0.0%    0.3%
  123       Cirrhosis of the liver                                0.1%     29     35       0.0%    26       24       0.1%     0.1%    0.0%    0.1%    0.1%    0.0%    0.0%    0.2%    0.0%    0.2%    0.1%    0.0%    0.1%
  156       Fire, heat, and hot substances                        0.2%     26     36       0.0%    27       22       0.1%     0.3%    0.0%    0.2%    0.2%    0.0%    0.1%    0.2%    0.0%    0.2%    0.1%    0.0%    0.1%
  158+159   Other unintentional injuries including other forces   1.2%     15     37       0.0%    28       12       1.2%     1.9%    0.0%    1.8%    0.8%    0.0%    0.8%    1.5%    0.0%    1.7%    0.7%    0.0%    0.7%
  157       Drowning                                              0.0%     36     38       0.0%    29       29       0.0%     0.1%    0.0%    0.0%    0.0%    0.0%    0.0%    0.1%    0.0%    0.0%    0.0%    0.0%    0.0%
  71        Cervix uteri cancer                                   0.0%     39     39       -0.1%   30       28       0.0%     0.0%    0.0%    0.0%    0.0%    0.0%    0.0%    0.0%    0.0%    0.0%    0.0%    -0.3%   0.0%

Abbreviations: YLDs, years lived with disability; GHE, Global Health Estimates; KNHANES, Korea National Health and Nutrition Examination Survey; ROK, Republic of Korea; COPD, chronic obstructive pulmonary disease.

^a^ The combined YLDs from all the conditions investigated in this study.

^b^ The combined YLDs from all the investigated conditions available in regional estimates.

^c^ Age 20−59 years in this study or age 15−59 years in WHO's global and regional estimates.

The five leading causes of YLDs were back pain, depression, alcohol-use disorders, diabetes, and stroke, in young males, whereas these were back pain, depression, osteoarthritis, alcohol-use disorders, and caries in young females. Back pain, osteoarthritis, stroke, hearing impairment, and CKD were the top-five YLD causes in old males, while back pain, osteoarthritis, periodontitis, stroke and diabetes ranked highest in old females.

Discussion {#sec014}
==========

We here readily estimated population-level YLDs for noncommunicable diseases and injuries using a prevalence-based approach, in which we measured the disability-weight in subjects with specific disease or injury. To the best of our knowledge, this is the first report to date estimating YLDs for numerous conditions using prevalence rates and disability-weights both measured in a representative sample. This new approach revealed that the increase of combined YLDs from noncommunicable diseases with ageing, which is more distinct in females, was mostly due to the exceptionally large YLDs ascribed to back pain and osteoarthritis, particularly in old females.

Back pain and osteoarthritis were very common, particularly in old females, and the disability-weights for those diseases were exceptionally large. The disability-weights were also large for visual impairments (except in uncorrected refractive errors) and stroke, but the prevalence rates of these conditions were much lower than those of back pain or osteoarthritis. Diabetes, alcohol-use disorders, hearing impairment, COPD, CKD, and periodontitis were also very common, but the disability-weights were not as large as those for back pain or osteoarthritis.

Our study findings differed somewhat from those of the GHE. The condition-specific YLDs for many diseases and injuries (except for back pain, osteoarthritis, periodontitis, stroke, CKD, caries, or peptic ulcer) were lower than those of the GHE, and the combined YLDs for all conditions in most age−sex groups (except in old females) were also lower than those of the WHO estimates. In contrast to the WHO estimates, the combined YLDs in our study differed markedly between males and females. The differences in male and female health-related quality of life have been observed not only in our study of the Korean population, but also in studies of other ethnic populations \[[@pone.0172001.ref020]--[@pone.0172001.ref022]\].

The GBD 2010 used lay descriptions of the symptoms and dysfunctions resulting from diseases or injuries to estimate disability-weights for those conditions, and obtained highly consistent values across surveys performed in diverse communities \[[@pone.0172001.ref009]\]. Although these brief descriptions were straightforward, they may fail to reflect different manifestations of any given disease in terms of severity, treatment, or environment. A number of studies have evaluated DALYs or YLDs for various diseases \[[@pone.0172001.ref023]--[@pone.0172001.ref027]\], and most have used health state descriptions to estimate disability-weights, following the GBD and WHO method. It is doubtful that the abstract values of disability-weights obtained using descriptions that assume typical manifestations of diseases could reflect a real-life health state. Previous YLDs differed markedly across previous studies, particularly in the case of mild disease \[[@pone.0172001.ref028]\]. The manifestations of disease may vary from asymptomatic to apparently symptomatic depending on individual conditions and environments. In general, mild disease states, with no or vague symptoms, are common, whereas severe states, with apparent symptoms, are relatively uncommon. If a disability-weight for a severe, uncommon disease state is used to estimate the YLDs of a mild common disease state, the YLDs may be erroneously overestimated. The lack of population information on the severity distribution of most conditions may frequently lead to mismatch errors between prevalence rates and disability-weights in the calculation of YLDs. These types of mismatch errors can be avoided by measuring both values from a single study sample.

A few studies have assessed DALYs or YLDs using a disability-weight that was directly measured in patients with specific diseases or injuries \[[@pone.0172001.ref005],[@pone.0172001.ref029]--[@pone.0172001.ref033]\]. However, most of them evaluated YLDs for only one or two conditions, and even did so without reasonable reference groups. The aggregate of separate estimations of YLDs for various diseases, without relevant mutual exclusions between disease categories, may result in overestimation of total YLDs, due to the duplications of the YLDs. The GHE list, from which we identified specific diseases and injuries for this study, may provide mutually exclusive and aggregative categories. In our study, the disability-weight was measured in subjects with a specific disease or injury; both the prevalence and disability-weight were measured in a representative sample, and the YLDs from dozens of conditions in the GHE list were estimated from the same source. Thus, our estimates of the condition-specific and combined YLDs were more likely to reflect the real health state of the population and to overcome erroneous estimation due to mismatch errors or duplicated counts.

There was a marked, age-related increase in YLDs ascribed to osteoarthritis and back pain, with a notable difference between males and females. The YLDs from osteoarthritis and back pain were exceptionally large, particularly for older females. The combined YLDs from both these conditions accounted for 31.5% of all-cause YLDs in adults aged ≥ 20 years. In the Global Burden of Disease (GBD) 2010 and WHO GHE, back pain and osteoarthritis also ranked highest. However, the YLDs from those were not as marked as in our estimates, and did not differ between the sexes. Our finding of the sex differences in YLDs for back pain and osteoarthritis could possibly explain the worse health-related quality of life in females, which has also been demonstrated in previous studies performed in other ethnic groups \[[@pone.0172001.ref020]--[@pone.0172001.ref022]\]. For osteoarthritis, the differences in YLDs for the two sexes resulted mainly from the difference in prevalence rates. The prevalence of osteoarthritis in females was markedly higher than that in males, while the disability-weight was similar between the sexes. As we confirmed osteoarthritis from radiographs as well as from symptoms, our prevalence estimate is reliable.

On the other hand, back pain, the single highest-ranked condition, was common in young people as well as in old people. However, the disability-weight from back pain was relatively small in young people as compared to old people. Back pain has diverse causes, including osteoarthritis, herniated disks, instability, spinal stenosis, and the sequelae of spine surgery, and is most frequently diagnosed as "nonspecific back pain" \[[@pone.0172001.ref034]\]. In our study, in half of old people with back pain, this disorder was accompanied by radiographic osteoarthritis, but this accompanying rate was sharply decreased in young people. Further research is urgently needed to define the broad category of "back pain" better.

Additionally, the YLD estimates of our study incorporate the effect of current treatments as well as the severity of the disorder itself. This point should be considered when interpreting our results. Back pain and osteoarthritis should receive greater emphasis in terms of disability, particularly in older women. However, preventative strategies or brief supportive care, rather than traditional or specialized treatments, may be more effective in reducing osteoarthritis and back pain \[[@pone.0172001.ref035],[@pone.0172001.ref036]\].

Diabetes is another important cause of disability. The YLDs from diabetes were 72000 years and accounted for 3.3% of all-cause YLDs. Diabetes is a common disease that has various complications. The GBD 2010 and WHO GHE used discrete disability-weights according to the complication of diabetes (uncomplicated, diabetic foot, and diabetic neuropathy). However, it may be difficult to establish the distribution of complications at the age, sex, and regional level. In the KNHANES sample, the microvascular complication rates of diabetes differed according to age and sex. Diabetic retinopathy/nephropathy (urine albumin-to-creatinine ratio ≥ 30 mg/g) was observed in 13.7%/19.1%, 13.9%/19.7%, 20.2/29.7%, and 19.5/24.7% of the young-male, young-female, old-male, and old-female diabetics, respectively. In our study, the disability-weight ascribed to diabetes was 0.015, 0.021, 0.026, and 0.021, in the young males, young females, old males, and old females, respectively. We believe that our data represent more reliable disability-weights and YLDs for diabetes at the age and sex level.

Depression and alcohol-use disorders are well known to be major contributors to disability. The YLDs from depression/alcohol-use disorders accounted for 4.6%/2.0% of all-cause YLDs, respectively, and the values were notably different from the WHO's global (10.8%/4.3%) and regional (7.5%/7.6%) estimates. This large difference was caused by the marked differences in the disability-weights between the GHE and our study. The GHE disability-weights for major depression and alcohol-use disorders ranged from 0.159 to 0.655, but the overall disability-weights for depression and alcohol-use disorders were 0.072 and 0.017, respectively, in our study. The disability due to these mental and behavioral disorders could easily be affected by the social or cultural environment. Moreover, the severity of the disorders could be differently regarded by the patients themselves and by those around them. We obtained disability-weights from a self-reported questionnaire (EQ-5D), using the Korean value set that was established based on a representative national sample. The disability-weights and YLDs of our research therefore incorporate cultural effects and self-assessments.

The overall YLDs from visual impairment (including uncorrected refractive errors) accounted for 2.3% of all-cause YLDs. In adults aged ≥ 20 years, the overall prevalence of visual impairments (including blindness) with best-corrected visual acuity \< 8/16 in the better eye was 1.58%, and the prevalence of uncorrected refractive errors was 3.85%. When each cause was calculated as a percentage of total causes of visual impairment (excluding uncorrected refractive errors), the causes were cataract (62.0%), glaucoma (10.1%), age-related macular degeneration (8.3%), diabetic retinopathy (3.6%), and undetermined causes (16.0%). Visual impairment from undetermined causes did not decrease the EQ-5D index scores in our study (data not shown), although that was the largest global cause of YLDs ascribed to visual impairment according to the GHE. Cataracts, uncorrected refractive errors, and macular degeneration were the top three contributors to YLDs due to visual impairment. A total of 29487 adults underwent ophthalmologic examinations in the KNHANES from July 2008 to December 2012, and trained medical staff and ophthalmologists conducted the examinations using standardized equipment and protocols. Our results may be helpful for the estimation of the global or regional burden of visual impairment.

The combined YLDs from all injuries accounted for 2.6% of all-cause YLDs. Falls and road injury accounted for 95.7% of the total YLDs from all injuries. Falls and road injury were common in old women and in young men, respectively. Although the sequelae of injuries may have a wide spectrum of severity, it may be very hard to identify the severity distribution of sequelae at the population level. Previous studies performed in European countries have suggested that injuries are main contributors to YLDs, as well as years of life lost (YLLs) \[[@pone.0172001.ref033],[@pone.0172001.ref037]\]. Those studies analyzed the data based on the disability-weights obtained from patients in hospital or emergency settings. The disability-weights obtained from hospitalized patients or emergency department attendances would reflect disability for severe injuries, but would not represent disability for injuries of various states. As mentioned earlier, if the disability-weight for severe injuries was applied to a mild state, the YLDs may be overestimated. In contrast, our research was based on the KNHANES, which involved non-institutionalized civilians only, and investigated recent (within 1 year) injuries. People with severe conditions or lifelong sequelae were more likely to be excluded, and our results may underestimate the YLDs from injuries.

Stroke/ischemic heart disease accounted for 166/98 YLDs per 100000 adults and 2.9%/1.7% of all-cause YLDs in our study, whereas they accounted for 130/186 YLDs per 100000 adults and 1.2%/1.7% of all-cause YLDs in the WHO's regional estimates. Percutaneous coronary intervention is well known to provide a benefit in terms of quality of life in patients with ischemic heart disease \[[@pone.0172001.ref038]\]. The existence of effective treatment may result in the contrasting YLDs between diseases. Disability due to hearing impairment could also be affected by the availability of medical resources. A substantial improvement in the mental health quality of life after cochlear implant or hearing aid use has been reported in patients with hearing impairments \[[@pone.0172001.ref039]\]. It is quite possible that the YLDs from hearing impairment are smaller (our estimates) than expected (WHO's global estimates) with the aid of these modalities. The YLDs from chronic obstructive pulmonary disease was less than the WHO's global or regional estimates. In old females the degree of decreased forced expiratory volume in 1 second did not correlate with the severity of disability. It remains possible that the assessment of chronic obstructive pulmonary disease based only on the results of a pulmonary function test cannot readily estimate the severity in old females. Chronic kidney disease also contributes to YLDs. Interestingly, chronic kidney disease with moderately increased risk significantly contributed to YLDs only in old men, whereas a more advanced state (with high risk) did not in old men. The potential overestimation of the glomerular filtration rate in the case of muscle wasting, a common problem in the elderly suffering from kidney disease, may influence the association between disability and estimated kidney function in old people. Peptic ulcer accounted for 1.5% of all-cause YLDs, and the value was larger than the WHO's global (0.1%) and regional (0.2%) estimates. We believe that the relatively larger YLDs due to peptic ulcer reflect the regional differences in the characteristics of peptic ulcers \[[@pone.0172001.ref040]\]. Oral health disorders (dental caries, periodontitis, and edentulism) were important contributors to YLDs. Oral health disorder is a preventable disease and is related to general hygiene. It is therefore necessary to emphasize the importance of oral hygiene. The magnitude of YLDs due to cancers was relatively small. Malignancy is a well-known major contributor to YLLs, but the YLDs due to malignancy is not thought be large. Nevertheless, colorectal and lung cancers in old males and breast cancer in females were significant contributors to YLDs. Interestingly, iron-deficiency anemia, contributed to YLDs only in males. The causes of iron deficiency, physical activity, or comorbidities may be involved in the association between iron-deficiency anemia and YLDs. Overall, these findings suggest that multifactorial processes are involved in the determination of health-related quality of life in the general population.

Taken together, the YLDs estimated in this study differed somewhat from those of the GBD 2010 and WHO GHE. The differences might arise from three different sources. First, we estimated the prevalence rates of 40 conditions in a single representative sample, whereas those of the GBD and GHE were obtained from various sources. Additionally, we confirmed many diseases by objective physical/laboratory findings along with patient's symptoms, to obtain more precise estimates of disease prevalence. Our estimates might provide a more consistent and reliable source for comparing disease burdens among numerous conditions. Second, we generated disability-weights from the EQ-5D index directly measured in a large sample from the KNHANES, whereas the GBD 2010 measured disability-weights using lay health-state descriptions, which could not reflect various manifestations of the same disease particularly in terms of severity. Additionally, we computed disability-weights separately in each age and sex category (young males, young females, old males, and old females). Disease burdens estimated in our study might incorporate age-specific effects as well as the severity of the disorder. Finally, we could overcome erroneous estimation of YLDs from mismatch errors between prevalence rates and disability-weights through measuring them in a single study sample. The GBD rankings are based on epidemiological data that may not be sufficiently robust for the calculation of the YLDs; the lack of reliable information on severity distributions may lead to mismatch errors in the calculation of YLDs. We believe that our YLD estimates are more likely to reflect real health states of the population.

On the other hand, the use of computed disability-weights from people having health conditions is not necessary an advantage compared to the weights that use lay health-state descriptions as a basis. Since persons with health conditions tend to underestimate their level of disability, the use of weights based on lay descriptions is the most conservative approach. In addition, disability-weights based on lay descriptions have been preferred for the estimation of disease burdens because they take into account the opinion of the general population.

There are several points to consider when interpreting our results. First, we did not investigate all the causes of YLD in the GHE list. In addition to the investigated diseases, anxiety disorders, migraine, schizophrenia, drug-use disorders, and gynecologic disorders are important contributors to the global disease burden. We could not include such conditions, due to the lack of relevant information in the KNHANES data. However, the combined YLDs from the conditions included in this study accounted for 61.7% of all-cause YLDs in the WHO's global estimates. Additionally, we investigated visual/hearing impairments and oral health disorders, which were not included in the WHO's regional estimates. Second, certain diseases were defined by a physician-based diagnosis of the disease, while many other diseases were confirmed by physical/laboratory examinations, in conjunction with the patient's history. The prevalence of a diagnosed disease could different from the true prevalence. Some diagnoses may have been incorrect or missed. Third, as the survey enrolled non-institutionalized individuals who volunteered to participate, persons with severe conditions were more likely to be excluded. Thus, the estimates would have been underestimated in the KNHANES. Finally, the present study included subjects who resided in Korea, and the disability-weights were generated based on the EQ5D index scores calculated using the Korean value set, which were closer to values of the Japanese study than those of studies in western countries \[[@pone.0172001.ref012]\]. Since there is likely to be regional or ethnic differences in disease burdens, it is difficult to draw general conclusions applicable to the global population. Nevertheless, the values of prevalence, disability-weight, and YLDs determined in our study may be helpful in estimating non-fatal burdens of diseases in East Asia, where populations with similar ethnic and cultural backgrounds reside.

Conclusions {#sec015}
===========

This relatively simple, prevalence-based approach, using a population-representative survey, could readily estimate YLDs reflecting the real health state of the general population. The results of this study may form the basis for population-level strategies to prevent age-related worsening of disability, which is more severe in females.

We express our gratitude to all the survey respondents and to members of the KNHANES.
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